Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/269733
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Predictors of clinically significant quality of life impairment in Parkinson’s disease |
Autor: | Santos-García, Diego; Deus Fonticoba, T. de; Cores Bartolomé, Carlos; Muñoz, Guillermo; Paz González, J. M.; Martínez Miró, Cristina; Suárez, Ester; Jesús Maestre, Silvia CSIC ORCID; Aguilar Barberá, Miquel; Pastor, Pau; Planellas, Lluís; Cosgaya, Marina; García Caldentey, Juan; Caballol, Nuria; Legarda, Inés; Hernández-Vara, Jorge; Cabo-Lopez, Iria; López Manzanares, Luis; González-Aramburu, Isabel; Ávila-Rivera, María A.; Catalán, M. J.; Nogueira, Víctor; Puente, Víctor; Ruíz de Arcos, María; Borrué, Carmen; Solano Vila, Berta; Álvarez-Sauco, María; Vela, Lydia; Escalante, Sonia; Cubo, Esther; Carrillo Padilla, Francisco; Martínez-Castrillo, J. C.; Sánchez Alonso, Pilar; Alonso Losada, María G.; López-Ariztegui, Nuria; Gastón, Itziar; Clavero, Pedro; Kulisevsky, Jaime; Blázquez-Estrada, Marta; Seijo-Martínez, Manuel; Ruiz Martínez, Javier; Valero, Caridad; Kurtis, Mónica; Fábregues-Boixar, Oriol de; González Ardura, Jessica; Ordás, Carlos; López-Díaz, Luis M.; McAfee, Darrian; Martínez-Martín, Pablo; Mir, Pablo CSIC ORCID | Fecha de publicación: | 16-dic-2021 | Editor: | Springer Nature | Citación: | npj Parkinson's Disease 7: 118 (2021) | Resumen: | Quality of life (QOL) plays an important role in independent living in Parkinson’s disease (PD) patients, being crucial to know what factors impact QoL throughout the course of the disease. Here we identified predictors of QoL impairment in PD patients from a Spanish cohort. PD patients recruited from 35 centers of Spain from the COPPADIS cohort from January 2016, to November 2017, were followed up during 2 years. Health-related QoL (HRQoL) and global QoL (GQoL) were assessed with the 39-item Parkinson’s disease Questionnaire (PDQ-39) and the EUROHIS-QOL 8-item index (EUROHIS-QOL8), respectively, at baseline (V0) and at 24 months ± 1 month (V2). Clinically significant QoL impairment was defined as presenting an increase (PDQ-39SI) or decrement (EUROHIS-QOL8) at V2 ≥ 10% of the score at baseline (V0). A comparison with a control group was conducted for GQoL. GQoL did not change significantly in PD patients (N = 507; p = 0.686) or in the control group (N = 119; p = 0.192). The mean PDQ-39SI was significantly increased in PD patients (62.7 ± 8.5 years old; 58.8% males; N = 500) by 21.6% (from 16.7 ± 13 to 20.3 ± 16.4; p < 0.0001) at V2. Ninety-three patients (18.6%) presented a clinically significant HRQoL impairment at V2. To be younger (OR = 0.896; 95% CI 0.829–0.968; p = 0.006), to be a female (OR = 4.181; 95% CI 1.422–12.290; p = 0.009), and to have a greater increase in BDI-II (Beck Depression Inventory-II) (OR = 1.139; 95% CI 1.053–1.231; p = 0.001) and NMSS (Non-Motor Symptoms Scale) (OR = 1.052; 95% CI 1.027–1.113; p < 0.0001) total scores from V0 to V2 were associated with clinically significant HRQoL impairment at the 2-year follow-up (Hosmer–Lemeshow test, p = 0.665; R 2 = 0.655). An increase in ≥5 and ≥10 points of BDI-II and NMSS total score at V2 multiplied the probability of presenting clinically significant HRQoL impairment by 5 (OR = 5.453; 95% CI 1.663–17.876; p = 0.005) and 8 (OR = 8.217; 95% CI, 2.975–22.696; p = 0.002), respectively. In conclusion, age, gender, mood, and non-motor impairment were associated with clinically significant HRQoL impairment after the 2-year follow-up in PD patients. | Descripción: | COPPADIS Study Group. | Versión del editor: | http://dx.doi.org/10.1038/s41531-021-00256-w | URI: | http://hdl.handle.net/10261/269733 | DOI: | 10.1038/s41531-021-00256-w | Identificadores: | doi: 10.1038/s41531-021-00256-w e-issn: 2373-8057 |
Aparece en las colecciones: | (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
quality_life_Parkinson.pdf | 1,09 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
15
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
13
checked on 24-feb-2024
Page view(s)
78
checked on 23-abr-2024
Download(s)
64
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons